BIOMAT Database Logo BIOMAT Database Logo

[Progestogen therapy of benign prostatic hypertrophy]. 1970

K Nakayama, and K Okamoto

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011278 Pregnanes Saturated derivatives of the steroid pregnane. The 5-beta series includes PROGESTERONE and related hormones; the 5-alpha series includes forms generally excreted in the urine.
D011470 Prostatic Hyperplasia Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both. Adenoma, Prostatic,Benign Prostatic Hyperplasia,Prostatic Adenoma,Prostatic Hyperplasia, Benign,Prostatic Hypertrophy,Prostatic Hypertrophy, Benign,Adenomas, Prostatic,Benign Prostatic Hyperplasias,Benign Prostatic Hypertrophy,Hyperplasia, Benign Prostatic,Hyperplasia, Prostatic,Hyperplasias, Benign Prostatic,Hypertrophies, Prostatic,Hypertrophy, Benign Prostatic,Hypertrophy, Prostatic,Prostatic Adenomas,Prostatic Hyperplasias, Benign,Prostatic Hypertrophies
D002208 Caproates Derivatives of caproic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain a carboxy terminated six carbon aliphatic structure. Hexanoates,Caproic Acid Derivatives,Caproic Acids,Hexanoic Acid Derivatives,Hexanoic Acids,Acid Derivatives, Caproic,Acid Derivatives, Hexanoic,Acids, Caproic,Acids, Hexanoic,Derivatives, Caproic Acid,Derivatives, Hexanoic Acid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

K Nakayama, and K Okamoto
[Progestogen therapy for prostatic hypertrophy].
September 1970, Hinyokika kiyo. Acta urologica Japonica,
K Nakayama, and K Okamoto
[Current therapy of benign prostatic hypertrophy].
July 1986, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
K Nakayama, and K Okamoto
Alternative therapy for benign prostatic hypertrophy.
August 1994, Singapore medical journal,
K Nakayama, and K Okamoto
Using antiandrogen therapy in benign prostatic hypertrophy.
April 1977, Geriatrics,
K Nakayama, and K Okamoto
Benign prostatic hypertrophy: update on drug therapy.
September 2006, Canadian family physician Medecin de famille canadien,
K Nakayama, and K Okamoto
Benign prostatic hypertrophy.
August 1993, The Practitioner,
K Nakayama, and K Okamoto
Benign prostatic hypertrophy.
June 1994, Iowa medicine : journal of the Iowa Medical Society,
K Nakayama, and K Okamoto
Benign prostatic hypertrophy.
January 1993, European urology,
K Nakayama, and K Okamoto
Benign prostatic hypertrophy.
April 1957, Journal of gerontology,
K Nakayama, and K Okamoto
Benign prostatic hypertrophy.
July 1991, American family physician,
Copied contents to your clipboard!